Hypothalamic-pituitary dysfunction

Chairs

Hanneke M. van Santen, Wilhelmina Children’s Hospital, UMC Utrecht, Utrecht, The Netherlands and Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Wassim Chemaitilly, St. Jude Children’s Research Hospital, Memphis, United States

Coordinator

Laura van Iersel, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, the Netherlands

Advisors

Leontien C.M. Kremer, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands and Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, the Netherlands
Melissa M. Hudson, St. Jude Children’s Research Hospital, Memphis, United States
Renée L. Mulder, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Roderick Skinner, Great North Children’s Hospital and Northern Institute of Cancer Research, Newcastle University, Newcastle upon Tyne, UK
Louis S. Constine, University of Rochester Medical Center, Rochester, United States
W. Hamish Wallace, Royal Hospital for Sick Children, Edinburgh, United Kingdom

WG leaders

Laurie Cohen, Boston Children’s Hospital, Harvard Medical School, Boston, MA, United States
Christian Denzer, Ulm University Medical Center, Ulm, Germany
Lillian Meacham, Children’s Healthcare of Atlanta, Emory University, Atlanta, Georgia, United States
Helen Spoudeas, Great Ormond Street Hospital for Children and University College London Hospital, United Kingdom

WG members

Gregory T. Armstrong, St. Jude Children’s Research Hospital, Memphis, United States
Edit Bardi, Kepler Universitätsklinikum, Linz, Austria and Semmelweis University, Budapest, Hungary
Andrew Bauer, Children’s Hospital of Philadelphia, Philadelphia, United States
Sarah C. Clement, Emma Children’s Hospital/Academic Medical Center, Amsterdam, the Netherlands
Alberto Fernandez, La Paz University Hospital, Madrid, Spain
Cecilia Follin, Skåne University hospital and IKVL, Lund University, Lund, Sweden
Helena Gleeson, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
Eelco Hoving, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Natascia Di Iorgi, Giannina Gaslini Children’s Hospital, Genova, Italy
Geert Janssens, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Cecilie Kiserud, Oslo University Hospital, Oslo, Norway
Robert Murray, Leeds Teaching Hospitals National Health Service Trust, Leeds, United Kingdom
Sebastian Neggers, Sophia Children’s Hospital/Erasmus Medical Center, Rotterdam, the Netherlands and Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Sogol (Goli) Mostoufi-Moab, The Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States
Vera Morsellino, Istituto Giannina Gaslini, Genova, Italy
Roger Packer, School of Medicine and Health Sciences, George Washington University and Brain Tumor Institute, Center for Neuroscience and Behavioral Medicine, Children׳s National Health System, Washington, United States
Briana Patterson, Emory University, Atlanta, United States
Sripriya (Priya) Raman, Children’s Mercy Hospital, University of Missouri, Kansas City, Missouri, United States
Cécile M. Ronckers, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands and Institute for Biostatistics and Registry Research, Brandenburg Medical School, Neuruppin, Germany
Katrin Scheinemann, University of Basel Children’s Hospital, Basel, Switzerland
Netteke Schouten-van Meeteren, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Grit Sommer, University of Bern Institute of Social and Preventive Medicine (ISPM), Bern, Switzerland
Kumar Srivastava, St. Jude Children’s Research Hospital, Memphis, United States
Aline Stades, Wilhelmina Children’s Hospital, University Medical Center Utrecht, Utrecht, the Netherlands
Elaine Sugden, Oxford University Hospitals, NHS Foundation Trust, Oxford, United Kingdom
Cecile Thomas-Teinturier, Hôpital Bicêtre (Hôpitaux Universitaires Paris-Sud), Paris, France
Joel Thompson, University of Oklahoma Health Sciences Center, Oklahoma, United States
Andy Toogood, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom
Lililbeth Torno, Children’s Hospital of Orange County, United States
Dannis van Vuurden, VU University Medical Center, Amsterdam, the Netherlands
Kevin Yuen, Swedish Pituitary Center, Swedish Neuroscience Institute, Seattle, United States